Our mission is to make life better for patients suffering with debilitating diseases – and we believe our medicines will redefine what’s possible.
That means raising the bar for treatment expectations in the field of immunology, as we develop and launch medicines that may reduce the burden of diseases such as psoriasis, psoriatic arthritis, rheumatoid arthritis, lupus and gastrointestinal disorders.
It means advancing the treatment of migraine, severe headache disorders and pain, as we progress and expand our best-in-class pain portfolio with innovative, non-opioid solutions for patients who desperately need them.
And it means leading a next-generation approach to research and development in neurodegeneration, working to crack the code of devastating conditions such as Alzheimer's disease.
We embrace the challenge. Together, we'll redefine what's possible.